NutraCea stabilized rice bran factor in joint ventures
January 10, 2008
by Eric Schroeder
PHOENIX — NutraCea, a leader in stabilized rice bran (S.R.B.), nutrient research and technology, has formed two joint ventures with HerbalScience Singapore Ltd. Pte, a company that produces standardized botanical extracts for functional food and nutraceutical uses.
Under the terms of the agreements, NutraCea will have an 80% interest in Rice Science, a limited liability company that will develop certain extracts targeted for specific health conditions using S.R.B. The new company intends to focus on the areas of diabetes, arthritis and immunity.
The second company, Rice Rx, will be a limited liability company owned 50/50 by HerbalScience and NutraCea. It will advance drug discovery from S.R.B. for licensing to life science and pharmaceutical companies.
"Our ongoing clinical research continues to validate our beliefs regarding the inherent value of our proprietary products for various applications related to certain disease specific states such as joint health, immune response, diabetes, cardiovascular disease and more," said Brad Edson, chief executive officer of NutraCea. "We know that stabilized rice bran contains a rich bounty of natural compounds at therapeutic levels. We believe by isolating these specific elements, we can create quantifiable isolates that have the potential to be measurably effective in dealing with some of the most serious health threats that we face today. Additionally, many botanicals have been the basis for pharmaceutical drugs."